Long-Term Preservation of Ischemic Myocardium after Experimental Coronary Artery Occlusion
Open Access
- 1 March 1978
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 61 (3), 541-551
- https://doi.org/10.1172/jci108965
Abstract
The results of experiments with indirect methods have suggested that various interventions reduce infarct size after coronary artery occlusion. To determine and quantify directly both the short- and long-term effects of several interventions on myocardial salvage without relying on indirect methods, the left coronary artery was occluded in 880 rats; they were then given either no treatment or one of the following interventions: (a) hyaluronidase, an enzyme that hydrolyzes interstitial glycoproteins, 1,500 National Formulary (NF) U/kg i.v. 5 min and 24 h after occlusion; (b) cobra venom factor, a protein that depletes the third component of complement, 20 U/kg i.v. 5 min after occlusion; (c) a glucocorticoid: hydrocortisone, 50 mg/kg i.v. 5 min after occlusion; or the five-fold more potent methylprednisolone (MP): (i) 50 mg/kg i.v. 5 min after occlusion or (ii) 50 mg/kg i.v. 5 min after occlusion followed by 50 mg/kg i.m. 3, 6, and 24 h after occlusion; or (d) reserpine, an agent that depletes the heart of catecholamines, 0.5 mg/kg i.m. once on each of the 3 days before occlusion. The animals were sacrificed either 2 days after occlusion, i.e., at the time of peak necrosis, or after 3 wk, i.e., after the infarct was completely healed. The amount of preserved myocardium was then assessed by two independent techniques: planimetric measurement of serial histologic sections and creatine kinase activity of the whole left ventricle. The amount of normal myocardium preserved at 21 days postocclusion was significantly increased, by 22.3±7.8% (P < 0.025) after the administration of hyaluronidase, by 25.3±5.8% (P < 0.005) after cobra venom factor, by 14.5±6.9% (P < 0.05) after hydrocortisone, by 20.8±8.2% (P < 0.025) after the single dose of MP, by 20.9±3.9% (P < 0.001) after the four doses of MP, and by 10.2±3.7% (P < 0.05) as a result of pretreatment with reserpine. The four doses of MP significantly thinned the infarct—by 25.6±2.9% (P < 0.001)—and although ventricular rupture did not occur, the intervention caused distension of the left ventricle as a result of stretching of the infarcted tissue during scar formation. Thus, myocardium acutely jeopardized by ischemia can be preserved on a long-term basis.This publication has 37 references indexed in Scilit:
- The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs.Circulation Research, 1977
- Favorable Effects of Hyaluronidase on Electrocardiographic Evidence of Necrosis in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1977
- Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.Circulation, 1977
- Quantitative study of infarcted myocardium in cardiogenic shock.Heart, 1970
- TIME RELATIONSHIP BETWEEN ADMINISTRATION OF CORTISONE AND WOUND HEALING IN RATS.1964
- PRINCIPLES AND METHODS FOR MORPHOMETRIC STUDY OF LUNG AND OTHER ORGANS1963
- Simple Techniques for the Surgical Occlusion of Coronary Vessels in the RatAngiology, 1960
- CARDIAC HYPERTROPHY AFTER CORONARY ARTERY LIGATION IN RATS1960
- THE PHARMACOLOGY OF RAUWOLFIA1956
- EXPERIMENTAL MYOCARDIAL INFARCTION. I. A. METHOD OF CORONARY OCCLUSION IN SMALL ANIMALSAnnals of Surgery, 1954